Big Tech’s quarter in four charts: AI splurge and cloud growth

In Today’s News

Big Tech’s quarter in four charts: AI splurge and cloud growth

Feb 6 (Reuters) – U.S. tech giants have predicted their spending would surge this year as they double down on artificial intelligence, sharpening investor scrutiny over whether these costly bets would generate enough returns to justify the sector’s high valuations.The group – including Alphabet, Microsoft, Am …

Read More »

Is AI’s Next Data Center in Space? [sponsor]
As AI demand explodes, power, cooling, and land are becoming major constraints. Morgan Stanley estimates up to $3 trillion will flow into AI data infrastructure in the coming years. Now, leading technologists believe the most scalable solution may be space-based AI compute. One emerging company is positioning itself at the infrastructure layer of this shift, aiming to provide the verification and trust backbone for future orbital data centers through a proven satellite partner. Tech leaders like Elon Musk, Jensen Huang, and Sam Altman agree the next phase of AI infrastructure is inevitable. Learn more about this rare public-market opportunity at the intersection of AI, blockchain, and space.

Work to be suspended on $16 billion New York City tunnel project on Friday

NEW YORK/WASHINGTON, Feb 6 (Reuters) – Work on the $16 billion New York City Hudson Tunnel Project will be suspended at 5 p.m. ET (2200 GMT) on Friday because President Donald Trump’s administration has refused to lift a four-month-old freeze on federal funding, the Gateway Development Commission said.The pro …

Read More »

Silver Just Doubled in 2025 – Is This the Market’s Next Major Trend? [sponsor]
While most of Wall St. watched gold, silver quietly became one of 2025’s strongest performers This early-stage name sits directly in front of this trend and is now gaining attention from major players across the market. See the Company Connected to Silver’s Breakout

Featured Article

Novo Nordisk plunge wipes $50 billion off obesity drug giant

Novo Nordisk, which was worth more than $600 billion in 2024, said it expected both its sales and operating profit to fall between 5% and 13% this year, affected by lower drug prices in the United States.That would be the company’s first revenue decline since 2017, according to LSEG data.”After a year in whic …

Read More »

Disclaimer: This is a paid advertisement for educational purposes only and does not constitute financial advice. Investing involves risk and may not be suitable for all individuals. Past performance does not guarantee future results.
Trading Cheat Sheet is owned and operated by PROTRADING RESEARCH LLC. We are not licensed financial advisors. Always consult with a certified financial professional before making investment decisions.

IMPORTANT NOTICE AND DISCLAIMER
Pro Trading Research, LLC (“PTR”), the owner of this website (the “Website”), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the “Publications”). The author or authors of those Publications are solely responsible for their contents. PTR has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. PTR will NOT be liable for any loss or damage caused by a reader’s reliance on information posted on the Website or contained in the Publications.

FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE.
This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company’s financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.b>

SUBSTANTIAL RISK IN INVESTMENT.
Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution. Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER
Neither PTR nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization.

Policies and contact:  Disclaimer  |  Privacy  |  Terms

Trading Cheat Sheet
203 N La Salle Street, Suite 2100 | Chicago, IL 60601

unsubscribe

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Recent Posts

Categories